NeuroNOS Deal Sparks Buzz: Recent discussions on social media have centered around Beyond Air's announcement that its subsidiary, NeuroNOS, will be 85% acquired by XTL Biopharmaceuticals. Many users are highlighting the potential value unlock for the company, with a reported milestone payment structure of up to $32.5 million. The stock has seen a dramatic surge, with some noting a price jump of over 160% in a single day.
Strategic Focus Applauded: Conversations also focus on how this deal allows Beyond Air to sharpen its focus on core respiratory treatments like LungFit PH. Several posts suggest this strategic move could bolster the company's financial position and fuel future growth. The high trading volume, reportedly exploding to 127 million shares against a 30-day average of 6 million, has further fueled excitement.
Note: This discussion summary was generated from an AI condensation of post data.
Beyond Air Insider Trading Activity
Beyond Air insiders have traded $XAIR stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $XAIR stock by insiders over the last 6 months:
- STEVEN A. LISI (CEO and Chairman of the Board) purchased 6,000 shares for an estimated $19,491
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Beyond Air Revenue
Beyond Air had revenues of $1.8M in Q2 2026. This is an increase of 127.82% from the same period in the prior year.
You can track XAIR financials on Quiver Quantitative's XAIR stock page.
Beyond Air Hedge Fund Activity
We have seen 15 institutional investors add shares of Beyond Air stock to their portfolio, and 27 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. removed 2,870,248 shares (-86.1%) from their portfolio in Q3 2025, for an estimated $6,630,272
- KINGDON CAPITAL MANAGEMENT, L.L.C. removed 889,850 shares (-95.0%) from their portfolio in Q3 2025, for an estimated $2,055,553
- ALYESKA INVESTMENT GROUP, L.P. added 759,061 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,753,430
- BLEICHROEDER LP added 49,573 shares (+134.3%) to their portfolio in Q3 2025, for an estimated $114,513
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 44,306 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $102,346
- VANGUARD GROUP INC added 31,814 shares (+43.8%) to their portfolio in Q3 2025, for an estimated $73,490
- VIRTU FINANCIAL LLC added 20,881 shares (+inf%) to their portfolio in Q3 2025, for an estimated $48,235
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Beyond Air Analyst Ratings
Wall Street analysts have issued reports on $XAIR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- D. Boral Capital issued a "Buy" rating on 08/21/2025
To track analyst ratings and price targets for Beyond Air, check out Quiver Quantitative's $XAIR forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
